Stocks In News - USFDA

1. Dr Reddy’s Labs’ has received an approval from US FDA and is launching Buprenorphine and Naloxone Sublingual Film, a therapeutic equivalent generic version of Suboxone
2. Buprenorphine and naloxone are used to treat adults with opioid addiction.
3. “Buprenorphine helps suppress withdrawal symptoms caused by discontinuation of opioid drugs, and naloxone reverses and blocks the effect of opioids. 
4. This combination of medications is used as part of a complete treatment program including prescription monitoring, counseling, and psychosocial support.
5. The Suboxone brand had US sales of approximately $1.86 billion MAT for the most recent twelve months ending in April 2018 according to IMS Health.